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Abstract 
We report the frequency of sexually transmitted infections (STIs) diagnosed in UK adult film 
industry performers. A total of 100 adult film performers regularly screened for STIs on an 
average of every three weeks. High rates of condomless sex were reported and there were 
STIs recorded during the 19-year period covered by this study (1996–2015). STIs recorded 
included gonorrhoea, chlamydia, non-gonococcal urethritis, genital warts, syphilis and 
Trichomonas vaginalis. 
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Background 
Some UK Adult Film Industry (AFI) employers recommend performers to have regular 
sexually transmitted infection (STI) screening, prior to filming, and require a ‘negative’ 
test/certificate.1 Adult film performers (AFPs) who have screening may regard testing 
as a harm reduction strategy; screening does not necessarily prevent sexual infections  
but may serve as an early warning system in relation to specific infections, e.g. human 
immunodeficiency virus (HIV), syphilis, gonorrhoea and chlamydia. Research in USA 
and UK on AFPs report that sexual intercourse is condomless 80%–90% of the time,2–7 
and the prevalence of STI is between 8% and 35%.  
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Aim 
The aim of this study is to ascertain the frequency of AFPs’ STI testing in the UK, in 
relation to infection diagnoses and sequalae. 
 
Methods 
Two audits were undertaken, by a sole master’s degree researcher, of 100 self-identified 
AFPs’ case notes at an inner London, England, specialist sexual health service for sex 
workers. The audits covered 2014–2015 (Audit 1) and 1996–2015 (Audit 2). 
 
In Audit 1, information was gathered on sexual orientation, sexual practices, frequency of 
attendance at clinic and prevalence of condomless sex in a single year. This selected time 
period in Audit 1 gave an up to date and detailed representation of consultations with GU 
physicians and nurses, in response to Adult Film Industry (AFI) recommendations. 
 
Audit 2 was the first in the UK to assess the prevalence of STIs among AFPs attending this 
clinic over a substantial period of time, 1996 to 2015. 
 
Results 
 
Selected results from Audit 1 show that between 2014 and 2015, 38% (n=38) of AFPs 
attended testing every three weeks, whereas two APFs choose weekly testing. There was a 
high occurrence of condomless sex acts by AFPs: 85% (n=530) compared to 15% (n= 94) 
intercourse with condom (Table 1). The percentage of condomless sex in the female AFPs’ 
professional work decreased slightly when compared to their personal lives (81% compared 
with 85%), whereas in male AFPs, the percentage decreased from 84% in personal life to 
91% in professional practice. Females were diverse in sex activities for work, including 16% 
(n=8) performing oro-anal sex (‘rimming’), 24% (n=12) mutual masturbation or ‘fingering’ 
and 38% (n=19) having received anal intercourse (Table 1).  
 
Table 1: Demographics and sexual practices among the 100 AFPs 2014 to 2015.  
 
Male Adult Film Performers 
(n=50) 
Female Adult Film Performers 
(n=50) 
Age (years) n % n % 
18–30 9 18 19 38 
31–39 16 32 14 28 
40–49 12 24 5 10 
>50 13 26 12 24 
Median age 39  32  
     
Sexual Orientation Private Professional Private Professional 
Heterosexual 42 45 42 37 
Homosexual 3 4 1 1 
Not Specified 3 0 4 6 
Bisexual 2 1 3 6 
Transgender 0 0 0 0 
     
Sexual Practice With Condom Condomless With Condom Condomless 
 n % n % n % n % 
Personal         
Oral 3 5 52 95 4 5 69 95 
Vaginal 18 29 45 71 14 19 60 81 
Anal 0 0 11 100 7 27 19 73 
Mutual Masturbation 0 0 0 0 2 40 3 60 
Oro-Anal 0 0 0 0 0 0 1 100 
Total 21 16  108  84 27  15 152 85 
         
Professional         
Oral 2 3 66 97 22 25 66 75 
Vaginal 7 13 48 87 6 12 44 88 
Anal 4 29 10 71 3 16 16 84 
Mutual Masturbation 0 0 0 0 1 8 11 92 
Oro-Anal 0 0 0 0 1 13 7 87 
Toys 0 0 2 100 0 0 0 0 
Total 13  9 126  91 33 19  144  81 
         
Combined Total 34  13 234  87 60  17 296 83 
 
Twenty-one female AFPs worked in other areas of sex work: 17 as escorts, 2 in escorting / 
webcamming and 2 worked at sex parties / swingers’ clubs. Two males worked as escorts. 
In Audit 2, 171 new diagnoses of STIs were recorded from 1996 to 2015 (genital warts (n=31), 
gonorrhoea (n=40), non-gonococcal urethritis (n=41) chlamydia (n=35), Trichomonas vaginalis 
(n=1) and syphilis (n=1)) (Table 2). There were no cases of HIV, hepatitis B or hepatitis C. Males 
were more likely to have an STI than females: 98 compared to 73. Hepatitis vaccination uptake 
showed 34 of the patients commenced hepatitis A and 77 commenced hepatitis B vaccination. 
 
Discussion 
 
UK AFPs demonstrate a preference for testing every 28 days (a self-determined AFI UK 
standard)8; however, US researchers recommended testing 7–14 days in order to minimise 
STIs.7,9 The US Free Speech Coalition responded to this shorter timeframe and introduced the 
Performer Availability Screening Services ‘Moratorium’ which recommends terminating filming 
if HIV is detected.10 No similar system exists in the UK and it is questionable how effective this 
policy is at preventing STIs/HIV, as no robust evidence exists. 
 
Our study highlighted females do not exclusively work in one genre of sex work, and further 
research utilising tools aimed at HIV prevention (condom use, Treatment as Prevention (TasP), 
Post Exposure Prophylaxis (PEP), (Pre-Exposure Prophylaxis (PrEP) and Undetectable equals 
Uninfectious (U=U) may be fruitful in the future. The study was conducted retrospectively and 
was limited due to reliance on presumed accurate documentation. An under-estimation of the 
prevalence of STIs in this cohort is possible, as online testing and treatment of STIs are now 
readily available, and/or the cohort could attend other National Health Service / private clinics.
  
Table 2. Sexual infections in 100 AFPs audit by gender and sexuality (1996 to 2015). 
Male AFPs Female AFPs 
All AFPs 
Bisexual Heterosexual Homosexual All Groups Bisexual Heterosexual Not specified All Groups All Groups 
 
 
% of 
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Diagnosed 
 
% of 
total Diagnosed 
 
% of 
total 
 
Diagnosed 
% of 
total 
 
Diagnosed 
% of 
total 
 
Diagnosed 
 
% of 
total Diagnosed 
 
% of 
total 
 
Diagnosed 
% of 
total 
 
Diagnosed 
% of 
total 
 
Diagnosed 
STIs (n)  STIs (n)  STIs (n) STIs (n) STIs (n)  STIs (n)  STIs (n) STIs (n) STIs (n) 
Non-gonococcal urethritis 20 4 
 
28 27 
 
21 3 26 34 4 1 
 
3 6 
 
0 0 3 7 11 41 
Gonorrhoea-male-urethral 0 0  3 3  0 0 2 3 n/a         n/a  
Gonorrhoea-rectal 5 1  0 0  7 1 2 2 0 0  3 6  0 0 2 6 2 8 
Gonorrhoea-suspected 0 0  0 0  0 0 0 0 0 0  2 5  0 0 2 5 1 5 
Gonorrhoea-oropharyngeal 15 3  5 5  0 0 6 8 0 0  3 7  0 0 3 7 4 15 
Gonorrhoea-uncomplicated 5 1  3 3  0 0 3 4 0 0  2 5  0 0 2 5 2 9 
Chlamydia 10 2  9 9  7 1 9 12 4 1  5 11  25 1 5 13 7 25 
Chlamydia-rectal 0 0  0 0  14 2 2 2 0 0  0 0  0 0 0 0 1 2 
Chlamydia-suspected 0 0  3 3  7 1 3 4 0 0  0 1  0 0 0 1 1 5 
Chlamydia-pharyngeal 15 3  0 0  0 0 2 3 0 0  0 0  0 0 0 0 1 3 
Gonorrhaea-cervical n/a         0 0  2 4  0 0 2 4 n/a  
Genital warts-first occurrence 0 0  9 9  29 4 10 13 0 0  5 11  0 0 4 11 8 31 
Genital warts-recurrence 20 4  15 14  14 2 15 20 0 0  2 4  50 2 2 6 5 19 
Molluscumcontagiosum 0 0  8 8  0 0 6 8 0 0  2 4  0 0 2 4 3 12 
Pelvic inflammatory disease n/a         4 1  3 6  0 0 3 7 n/a  
Genital herpes-first episode 5 1  4 4  0 0 4 5 0 0  0 1  0 0 0 1 2 6 
Genital herpes-recurrence 0 0  0 0  0 0 0 0 0 0  2 4  0 0 2 4 1 4 
Syphilis 0 0  0 0  0 0 0 0 0 0  0 1  0 0 0 1 0 1 
Trichomonas vaginalis n/a         0 0  0 1  0 0 0 1 n/a  
Total  19  85   14  118  3  77   3  83  186 
AFP: adult film performer; STI: sexually transmitted infection. 
 
 
 
 
 
 
 
 
An unexpected finding identified gonorrhoea in five self-identified heterosexual men’s 
pharynxes. This may support recommendations for three-site anatomical testing for 
gonorrhoea and chlamydia to reduce a possible reservoir of missed infections.4 
 
To conclude, a challenging interplay exists between performers, healthcare providers and 
film producers in attaining and improving sexual health among these sex workers. To 
address any deficits in optimum service provision, there is a need to develop specific UK 
national guidance for clinicians, including improved collaboration with established AFI 
organisations such as United Kingdom Adult Producers and ‘PORN4PREP’. It will also be 
important to undertake a proper review of the industry’s occupational safety 
mechanisms for performers and to question AFPs’ personal risk reduction strategies. 
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